company background image
7741

HOYA TSE:7741 Stock Report

Last Price

JP¥13.40k

Market Cap

JP¥4.8t

7D

5.1%

1Y

-8.7%

Updated

23 May, 2022

Data

Company Financials +
7741 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance6/6
Financial Health6/6
Dividends4/6

7741 Stock Overview

HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide.

Rewards

Earnings are forecast to grow 7.99% per year

Earnings grew by 31.1% over the past year

Risk Analysis

No risks detected for 7741 from our risk checks.

HOYA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for HOYA
Historical stock prices
Current Share PriceJP¥13,395.00
52 Week HighJP¥19,435.00
52 Week LowJP¥12,020.00
Beta0.63
1 Month Change3.44%
3 Month Change-10.34%
1 Year Change-8.66%
3 Year Change72.00%
5 Year Change145.78%
Change since IPO2,415.49%

Recent News & Updates

Shareholder Returns

7741JP Medical EquipmentJP Market
7D5.1%-0.2%0.7%
1Y-8.7%-7.6%-2.9%

Return vs Industry: 7741 underperformed the JP Medical Equipment industry which returned -7.6% over the past year.

Return vs Market: 7741 underperformed the JP Market which returned -2.9% over the past year.

Price Volatility

Is 7741's price volatile compared to industry and market?
7741 volatility
7741 Average Weekly Movement5.8%
Medical Equipment Industry Average Movement4.3%
Market Average Movement4.6%
10% most volatile stocks in JP Market9.1%
10% least volatile stocks in JP Market2.5%

Stable Share Price: 7741 is not significantly more volatile than the rest of JP stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 7741's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194137,245Eiichiro Ikedahttps://www.hoya.co.jp

HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company operates through three segments: Life Care, Information Technology, and Other. The Life Care segment offers healthcare products, including eyeglass and contact lenses; and medical products, such as medical endoscopes, laparoscopic surgical instruments, intraocular lenses, and prosthetic ceramic fillers and orthopedic implants.

HOYA Fundamentals Summary

How do HOYA's earnings and revenue compare to its market cap?
7741 fundamental statistics
Market CapJP¥4.85t
Earnings (TTM)JP¥164.51b
Revenue (TTM)JP¥661.47b

29.7x

P/E Ratio

7.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
7741 income statement (TTM)
RevenueJP¥661.47b
Cost of RevenueJP¥293.67b
Gross ProfitJP¥367.80b
Other ExpensesJP¥203.29b
EarningsJP¥164.51b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)450.63
Gross Margin55.60%
Net Profit Margin24.87%
Debt/Equity Ratio2.7%

How did 7741 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

25%

Payout Ratio

Valuation

Is HOYA undervalued compared to its fair value and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


29.73x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: 7741 (¥13395) is trading above our estimate of fair value (¥13394.11)

Significantly Below Fair Value: 7741 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 7741 is poor value based on its PE Ratio (29.7x) compared to the JP Medical Equipment industry average (13.7x).

PE vs Market: 7741 is poor value based on its PE Ratio (29.7x) compared to the JP market (12.2x).


Price to Earnings Growth Ratio

PEG Ratio: 7741 is poor value based on its PEG Ratio (3.7x)


Price to Book Ratio

PB vs Industry: 7741 is overvalued based on its PB Ratio (6.1x) compared to the JP Medical Equipment industry average (1.4x).


Future Growth

How is HOYA forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


8.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7741's forecast earnings growth (8% per year) is above the savings rate (0.02%).

Earnings vs Market: 7741's earnings (8% per year) are forecast to grow slower than the JP market (8.8% per year).

High Growth Earnings: 7741's earnings are forecast to grow, but not significantly.

Revenue vs Market: 7741's revenue (6% per year) is forecast to grow faster than the JP market (4% per year).

High Growth Revenue: 7741's revenue (6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 7741's Return on Equity is forecast to be high in 3 years time (24.7%)


Past Performance

How has HOYA performed over the past 5 years?

Past Performance Score

6/6

Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


10.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 7741 has high quality earnings.

Growing Profit Margin: 7741's current net profit margins (24.9%) are higher than last year (22.9%).


Past Earnings Growth Analysis

Earnings Trend: 7741's earnings have grown by 10% per year over the past 5 years.

Accelerating Growth: 7741's earnings growth over the past year (31.1%) exceeds its 5-year average (10% per year).

Earnings vs Industry: 7741 earnings growth over the past year (31.1%) exceeded the Medical Equipment industry 17.4%.


Return on Equity

High ROE: 7741's Return on Equity (21%) is considered high.


Financial Health

How is HOYA's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 7741's short term assets (¥683.0B) exceed its short term liabilities (¥147.4B).

Long Term Liabilities: 7741's short term assets (¥683.0B) exceed its long term liabilities (¥56.4B).


Debt to Equity History and Analysis

Debt Level: 7741 has more cash than its total debt.

Reducing Debt: 7741's debt to equity ratio has reduced from 7.1% to 2.7% over the past 5 years.

Debt Coverage: 7741's debt is well covered by operating cash flow (879.9%).

Interest Coverage: 7741 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is HOYA current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


0.97%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 7741's dividend (0.97%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.64%).

High Dividend: 7741's dividend (0.97%) is low compared to the top 25% of dividend payers in the JP market (3.7%).


Stability and Growth of Payments

Stable Dividend: 7741's dividends per share have been stable in the past 10 years.

Growing Dividend: 7741's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (24.6%), 7741's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (29.4%), 7741's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

8.0yrs

Average management tenure


CEO

Eiichiro Ikeda (51 yo)

8.92yrs

Tenure

JP¥112,000,000

Compensation

Mr. Eiichiro Ikeda serves as Representative Executive Officer and Chief Executive Officer at Hoya Corp. since March 1, 2022 and serves as its President since March 1, 2022 and served as Chief Technology Of...


CEO Compensation Analysis

Compensation vs Market: Eiichiro's total compensation ($USD875.95K) is below average for companies of similar size in the JP market ($USD1.60M).

Compensation vs Earnings: Eiichiro's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: 7741's management team is seasoned and experienced (8 years average tenure).


Board Members

Experienced Board: 7741's board of directors are considered experienced (7.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

HOYA Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: HOYA Corporation
  • Ticker: 7741
  • Exchange: TSE
  • Founded: 1941
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Implied Market Cap: JP¥4.846t
  • Shares outstanding: 365.06m
  • Website: https://www.hoya.co.jp

Number of Employees


Location

  • HOYA Corporation
  • Nittochi Nishishinjuku Building
  • 20th Floor
  • Tokyo
  • 160-8347
  • Japan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/23 00:00
End of Day Share Price2022/05/23 00:00
Earnings2022/03/31
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.